Subscribe to Updates in Legal, Economic & Regulatory Affairs

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Political Experts (outside Washington DC)

Articles with lock require a subscription to GLG News | Request a free trial
June 11, 2008
Payday Lenders Are On Their Way to Repeal Ohio Law
Analysis of: Group Starts Campaign to Repeal Payday Lending Law | www.dispatchpolitics.com
Author: GLG Expert Contributor
Payday lenders complete first steps needed to begin referendum. Payday lending group hires prominent spokeswoman.
June 9, 2008
Iran must either Back down or have a Showdown with the West
Analysis of: Israeli official says attack on Iran 'unavoidable' | www.msnbc.msn.com
Author: GLG Expert Contributor
Iran is pursuing the development of nuclear weapons, Iran is pursuing the development of more advanced missile delivery systems, Iran is in violation of the UN Security Council and the IAEA
May 27, 2008
Federal Incentives to Large Oil Companies
Analysis of: A plan to reduce the price of oil 60% | www.silobreaker.com
Author: GLG Expert Contributor
- Large Oil Companies - Government Incentives - Alternative Sources
Jeff StierMay 20, 2008
Bar On Genetic "Bias" Could Harm Consumers
Analysis of: Congress Passes Bill to Bar Bias Based on Genes | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
This bill would limit innovative health insurance products which could actually lower rates for consumers.
Jeff StierMay 20, 2008
Not Involved in Lead Paint Companies? Ignore This Case At Your Peril
Analysis of: High-stakes lead paint case to R.I. Supreme Court | www.boston.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
The outcome of this case has liability implications for industries beyond those potentially on the hook for lead paint. Invested in the energy sector? Pharmaceuticals? Biotech? Nanotech? Tech? This case is worth your attention.
Jeff StierMay 19, 2008
Food Waste Awareness Creates Market Opportunities
Analysis of: One Country’s Table Scraps, Another Country’s Meal | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
As reports of the food crisis reaches fever pitch, will there be new opportunities?
Jeff StierMay 8, 2008
Will The New Push To Limit DTC Advertising Advance?
Analysis of: New Rules on Drug Ads Sought | online.wsj.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
Billions of dollars in pharmaceutical revenue, a large chunk of the advertising industry, and public health implications are at stake as Congress once again considers stricter limits on direct to consumer (DTC) advertising.
Jeff StierApril 30, 2008
Generic Biologics Won't Get A Free Ride
Analysis of: Don't compromise the safety of biotech drugs | www.latimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
Allowing "generic" versions of biotech drugs to market without full safety testing would endanger consumers
Jeff StierFebruary 25, 2008
Good News on the Horizon for Pharmaceuticals
Analysis of: Justices Shield Medical Devices From Lawsuits | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
The decision on medical devices is good news for pharmaceuticals. If medicines get the same protection -- it could bode well -- for reasons beyond the obvious.
Jeff StierFebruary 19, 2008
Regulatory Change Could Mean Millions to Big Pharma
Analysis of: F.D.A. Seeks to Broaden Range of Use for Drugs | www.nytimes.com
Author: Jeff Stier, Associate Director, American Council on Science and Health
A proposed regulatory change proposed on the Friday before a holiday weekend could have a major impact on pharmaceutical profits (and consumer health).

Previous Page : 1 2 3 4 5 6 7 8 9 Next11 to 20 of 84

More GLG News in
Legal, Economic & Regulatory Affairs

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T17:45:17.637